GCP ClinPlus Co., Ltd. (GCP) is a combination of three well established companies: Beijing DMS Pharma Ltd., with CRO as its primary business; YiXie ZhongTai MedTech Consulting Ltd, committed to provide medical device product registration and relevant consultation; SMO unit, mainly engaged in Site Management Organization (SMO). All three companies are so mature and distinctive that they can take advantage of each other’s strengths. GCP provides clinical research solutions which are customized and comprehensive, of international standards and making full use of various network and resources. The services of GCP ClinPlus, with the untiring effort of innovation and extending to new field, cover the evaluation and counseling of new drug R&D, regulatory affairs, clinical trial monitoring and management, data management, statistical analysis, medical affair and training, involving fields of pharmaceutical, biological product and medical device. GCP is of a well trained professional team. All the operation team members have various professional backgrounds of clinical medicine, pharmacy or nursing etc. The management team is composed of group of senior people with deep knowledge of clinical medicine, pharmacy or biometrics and with rich experience of management. All of them have had over 10 years experience in various management positions in multinational pharmaceutical companies as well as famous CRO companies. October 18, 2011, a joint venture company was officially established between GCP ClinPlus and CMIC Group. The win-win cooperation would surely enhance the core competitiveness and open a new chapter of accelerating development of GCP. There are Over 450 permanent employees in our company accross China.